New weapon tested against superbug pneumonia
Disease control
Not yet recruiting
This is an early safety study testing a new drug called MP101 for adults with a specific, hard-to-treat bacterial pneumonia caused by Pseudomonas aeruginosa. The main goal is to see if MP101 is safe and how it behaves in the body when given alongside standard antibiotics. It's a …
Phase: PHASE1 • Sponsor: MicrobiotiX Co., Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC